Events & Presentations
On September 12th, 2024, Erez Raphael, CEO, and Steven Nelson, Chief Commercial Officer, provided a thorough overview of the company and highlighted the inflection point that the business is reaching in its commercial growth. Discussion topics included Twill/Dario product integration milestones, market position, pipeline opportunities, and refined go-to-market strategies across health plans, employers, and pharma under Steven’s leadership. A live investor Q&A at the end of the session highlighted areas of market interest.
Use the link below to access the webinar replay:
https://us02web.zoom.us/rec/share/d5ska5cQCY1N-0N4gVgIbSehr761TZulPCx1AhUpWBm_prtBg_AlnLcujqh38cfJ.P8vnosvWpZWAyFZs?startTime=1726163439000
Passcode: r8?kH7QN
Erez Raphael, CEO, and Rick Anderson, President, participated in a fireside chat at the Cowen Healthcare conference on March 6th, 2024 where they discussed the latest developments at Dario. Topics include:
Dario/Twill overview, Aetna launch, B2B growth, the market for multi-condition solutions, Winning new customers, GLP-1s, the Sanofi partnership and the 2024 outlook.
Use the link below to access the replay:
https://wsw.com/webcast/cowen154/drio/2016052.
Dario and Twill management hosted a conference call on February 21st, 2024 announcing Dario’s strategic acquisition of Twill, a leader in digital-led care. The combination enables Dario to create one of the most comprehensive digital offerings in the market for chronic conditions, spanning a wide spectrum of health and well-being needs from emotional health to the costliest chronic conditions. The transaction creates immediate scale, with three of the top eight national health plans, multiple Fortune 100 employers and several major pharmaceutical companies as customers.
Use these links to access the replay and transcript.
DarioHealth hosted an Investor Day on October 17th, 2023 in NYC. In a discussion about the rise of digital health and the clinical research shaping its future, the Dario management team was joined by respected industry leaders including Arnaud Robert, respected technology expert and former head of digital for Sanofi and Nike, and Felix Lee, U.S. Digital Healthcare Medical Head, Sanofi U.S.
A Dario client along with several members shared how these solutions are changing behaviors and improving health by delivering personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Dario’s executive management team provided a deep dive into the company’s product and market growth plans and highlighted the full potential of the company’s user-centric, multi-chronic condition digital health platform.
Hear what questions investors had for the team during the live Q&A session at the end of the presentation.
May 9, 2022
May 2, 2022
March 2, 2022
DarioHealth (DRIO) and Sanofi ink $30 million agreement | MobiHealthNews
January 5, 2022
December 16, 2021
November 12, 2021
Why we can't afford to pretend telehealth is digital health | MobiHealthNews
October 25, 2021
October 19, 2021
DarioHealth Launches MSK platform Dario Move | MobiHealthNews
August 31, 2021
August 16, 2021
Can an app be medicine? These companies think so. | Fast Company
Augut 9, 2021
In the feeding frenzy of health-tech deal-making, the little fish wield the power. | STAT Health
May 24, 2021
May 18, 2021
DarioHealth (DRIO) Expands Mental Health Foothold with wayForward Acquisition | MobiHealthNews